These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
335 related articles for article (PubMed ID: 21711977)
21. [Study on plasma levels of vasoactive intestinal peptide (VIP) in patients with allergic rhinitis]. Zhang RX Zhonghua Er Bi Yan Hou Ke Za Zhi; 1993; 28(3):165-6, 187-8. PubMed ID: 8217299 [TBL] [Abstract][Full Text] [Related]
22. Gene expression of vasoactive intestinal peptide receptors in human lung cancer. Szilasi M; Buglyo A; Treszl A; Kiss L; Schally AV; Halmos G Int J Oncol; 2011 Oct; 39(4):1019-24. PubMed ID: 21769421 [TBL] [Abstract][Full Text] [Related]
23. Vascular endothelial growth factor produced in nasal glands of perennial allergic rhinitis. Matsune S; Ohori J; Sun D; Yoshifuku K; Fukuiwa T; Kurono Y Am J Rhinol; 2008; 22(4):365-70. PubMed ID: 18702899 [TBL] [Abstract][Full Text] [Related]
24. Reduction of TLR2 gene expression in allergic and nonallergic rhinitis. Vanhinsbergh LJ; Powe DG; Jones NS Ann Allergy Asthma Immunol; 2007 Dec; 99(6):509-16. PubMed ID: 18219831 [TBL] [Abstract][Full Text] [Related]
25. Role of VPAC1 and VPAC2 in VIP mediated inhibition of rat pulmonary artery and aortic smooth muscle cell proliferation. St Hilaire RC; Murthy SN; Kadowitz PJ; Jeter JR Peptides; 2010 Aug; 31(8):1517-22. PubMed ID: 20452385 [TBL] [Abstract][Full Text] [Related]
26. Expression and localization of platelet-activating factor receptor in human nasal mucosa. Shirasaki H; Seki N; Kikuchi M; Kanaizumi E; Watanabe K; Konno N; Himi T Ann Allergy Asthma Immunol; 2005 Aug; 95(2):190-6. PubMed ID: 16136770 [TBL] [Abstract][Full Text] [Related]
27. Pituitary adenylate cyclase-activating peptide/vasoactive intestinal peptide receptors in human normal mammary gland and breast cancer tissue. García-Fernández MO; Collado B; Bodega G; Cortés J; Ruíz-Villaespesa A; Carmena MJ; Prieto JC Gynecol Endocrinol; 2005 Jun; 20(6):327-33. PubMed ID: 16019382 [TBL] [Abstract][Full Text] [Related]
28. Matrix metalloproteinases and their inhibitors in the nasal mucosa of patients with perennial allergic rhinitis. Shaida A; Kenyon G; Devalia J; Davies RJ; MacDonald TT; Pender SL J Allergy Clin Immunol; 2001 Nov; 108(5):791-6. PubMed ID: 11692106 [TBL] [Abstract][Full Text] [Related]
29. Increased expression of histamine H1 receptor mRNA in allergic rhinitis. Iriyoshi N; Takeuchi K; Yuta A; Ukai K; Sakakura Y Clin Exp Allergy; 1996 Apr; 26(4):379-85. PubMed ID: 8732234 [TBL] [Abstract][Full Text] [Related]
30. Expression levels of endogenous hydrogen sulfide are altered in patients with allergic rhinitis. Park SJ; Kim TH; Lee SH; Ryu HY; Hong KH; Jung JY; Hwang GH; Lee SH Laryngoscope; 2013 Mar; 123(3):557-63. PubMed ID: 23303708 [TBL] [Abstract][Full Text] [Related]
31. Down-regulation of vasoactive intestinal peptide and altered expression of its receptors in rat diabetic cardiomyopathy. Dvoráková MC; Pfeil U; Kuncová J; Svíglerová J; Galvis G; Krasteva G; König P; Grau V; Slavíková J; Kummer W Cell Tissue Res; 2006 Mar; 323(3):383-93. PubMed ID: 16344947 [TBL] [Abstract][Full Text] [Related]
32. Nuclear localization of vasoactive intestinal peptide (VIP) receptors in human breast cancer. Valdehita A; Bajo AM; Fernández-Martínez AB; Arenas MI; Vacas E; Valenzuela P; Ruíz-Villaespesa A; Prieto JC; Carmena MJ Peptides; 2010 Nov; 31(11):2035-45. PubMed ID: 20691743 [TBL] [Abstract][Full Text] [Related]
33. [The investigation for the neuropeptides of nasal septum in perennial allergic rhinitis patient]. Zhu Q; Zhang S; Wu J; Tang H Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2009 Apr; 23(8):339-42. PubMed ID: 19685709 [TBL] [Abstract][Full Text] [Related]
34. Nasal mucosal expression of the leukotriene and prostanoid pathways in seasonal and perennial allergic rhinitis. Westergren VS; Wilson SJ; Penrose JF; Howarth PH; Sampson AP Clin Exp Allergy; 2009 Jun; 39(6):820-8. PubMed ID: 19364335 [TBL] [Abstract][Full Text] [Related]
35. Neuronal markers in allergic rhinitis: expression and correlation with sensory testing. O'Hanlon S; Facer P; Simpson KD; Sandhu G; Saleh HA; Anand P Laryngoscope; 2007 Sep; 117(9):1519-27. PubMed ID: 17667132 [TBL] [Abstract][Full Text] [Related]
36. Genetic association of vasoactive intestinal peptide receptor with rheumatoid arthritis: altered expression and signal in immune cells. Delgado M; Robledo G; Rueda B; Varela N; O'Valle F; Hernandez-Cortes P; Caro M; Orozco G; Gonzalez-Rey E; Martin J Arthritis Rheum; 2008 Apr; 58(4):1010-9. PubMed ID: 18383379 [TBL] [Abstract][Full Text] [Related]
37. Effect of vasoactive intestinal peptide on gastric adenocarcinoma. Li GH; Qian W; Song GQ; Hou XH J Gastroenterol Hepatol; 2007 Aug; 22(8):1328-35. PubMed ID: 17559364 [TBL] [Abstract][Full Text] [Related]
38. Expression of mRNAs for PACAP and its receptor in human neuroblastomas and their relationship to catecholamine synthesis. Isobe K; Kaneko M; Kaneko S; Nissato S; Nanmoku T; Takekoshi K; Okuda Y; Kawakami Y Regul Pept; 2004 Dec; 123(1-3):29-32. PubMed ID: 15518890 [TBL] [Abstract][Full Text] [Related]
39. Overexpression of the superoxide anion and NADPH oxidase isoforms 1 and 4 (NOX1 and NOX4) in allergic nasal mucosa. Moon JH; Kim TH; Lee HM; Lee SH; Choe W; Kim HK; Lee JH; Oh KH; Lee SH Am J Rhinol Allergy; 2009; 23(4):370-6. PubMed ID: 19671250 [TBL] [Abstract][Full Text] [Related]
40. Nasal mucosal gene expression in patients with allergic rhinitis with and without nasal polyps. Fritz SB; Terrell JE; Conner ER; Kukowska-Latallo JF; Baker JR J Allergy Clin Immunol; 2003 Dec; 112(6):1057-63. PubMed ID: 14657858 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]